- Report
- August 2022
- 118 Pages
Global
From €4009EUR$4,500USD£3,488GBP
- Report
- August 2022
- 120 Pages
Global
From €4009EUR$4,500USD£3,488GBP
- Report
- August 2022
- 115 Pages
Global
From €4009EUR$4,500USD£3,488GBP
- Report
- August 2022
- 119 Pages
Global
From €4009EUR$4,500USD£3,488GBP
- Report
- September 2024
- 187 Pages
Global
From €4009EUR$4,500USD£3,488GBP
- Report
- January 2023
- 50 Pages
China
From €2672EUR$3,000USD£2,325GBP
- Report
- July 2022
- 50 Pages
China
From €3207EUR$3,600USD£2,790GBP
- Report
- July 2021
- 50 Pages
China
From €2316EUR$2,600USD£2,015GBP
- Report
- July 2021
- 50 Pages
China
From €2316EUR$2,600USD£2,015GBP
- Report
- July 2021
- 50 Pages
China
From €2316EUR$2,600USD£2,015GBP
- Report
- August 2019
- 30 Pages
China
From €1960EUR$2,200USD£1,705GBP
- Report
- November 2018
- 30 Pages
China
From €1960EUR$2,200USD£1,705GBP
- Report
- November 2018
- 30 Pages
China
From €1960EUR$2,200USD£1,705GBP
- Report
- July 2018
- 30 Pages
China
From €1960EUR$2,200USD£1,705GBP
- Report
- December 2023
- 171 Pages
Global
From €3563EUR$4,000USD£3,101GBP
- Report
- October 2023
- 259 Pages
Global
From €3563EUR$4,000USD£3,101GBP
- Report
- September 2023
- 50 Pages
Global
From €2227EUR$2,500USD£1,938GBP
- Report
- July 2024
- 100 Pages
Global
From €3341EUR$3,750USD£2,907GBP
- Drug Pipelines
- July 2024
- 150 Pages
Global
From €3341EUR$3,750USD£2,907GBP
- Report
- July 2024
- 100 Pages
Global
From €3341EUR$3,750USD£2,907GBP

The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events.
The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more